The development and successful approval and distribution of new drugs and therapies increasingly relies on the strategic partnerships forged across pharma, biotech, academia, tech and beyond. At the same time globalization, digital transformation, economic factors, and other industry forces are bringing about more mergers and acquisitions, and part
09-10 May 2023